-
Syngene Q3 profit jumps 31% to Rs 59 cr.
Business Standard-21/01/2016. Syngene reported a 31% jump in third quarter profits to Rs 59 crore and 23% growth in revenues to Rs 281 crore on improved business from its global clients to help build new drug discovery.
-
India has 'natural potential to grow' in CRO space, says Syngene CEO
Outsourcing Pharma-14/01/2016. An exclusive interview with Peter Bains- CEO ,Syngene International Ltd -
-
Syngene appoints Jonathan Hunt as CEO-designate.
Business Today-05/01/2016. Syngene appoints Jonathan Hunt as CEO-designate. Mr Hunt to take charge post retirement of current CEO Peter Bains. Mr Bains will continue as a member of the Syngene Board.
Archives
-
2019
-
2018 (13)
-
2017 (10)
-
2016 (9)
-
2015 (10)